NCT07270692 Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence
| NCT ID | NCT07270692 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eko Devices, Inc. |
| Condition | Low Ejection Fraction |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2027-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2025-08-01 with a primary completion date of 2027-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objectives of this study are to train and evaluate an algorithm that predicts whether an individual has an ejection fraction ≤ 40%, using heart sounds and a 3-lead ECG as inputs, as well as determine the impact of gender, age, and race on algorithm performance.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years and older * Able and willing to provide informed consent * Complete a clinical echocardiogram within 7 days before or after study procedures Exclusion Criteria: * Unwilling or unable to provide informed consent * Patients who are hospitalized
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07270692 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Low Ejection Fraction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07270692 currently recruiting?
Yes, NCT07270692 is actively recruiting participants. Contact the research team at jackrin.walsh@ekohealth.com for enrollment information.
Where is the NCT07270692 trial being conducted?
This trial is being conducted at Mumbai, India.
Who is sponsoring the NCT07270692 clinical trial?
NCT07270692 is sponsored by Eko Devices, Inc.. The trial plans to enroll 500 participants.